{"url_path":"/sec/bkyi/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-021335-index.html","accession_number":"0001437749-26-021335","cik":"0001019034","ticker":"BKYI","issuer_name":"BIO KEY INTERNATIONAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-021335-index.html","primary_entity_key":"0001019034","primary_entity_name":"BIO KEY INTERNATIONAL INC"},"word_count":60,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n \n\nDuring the *three* months ended *March 31, 2026*, none of our directors or “officers” (as defined in Rule *16a*-*1*(f) under the Securities Exchange Act of *1934,* as amended) adopted or terminated a “Rule *10b5*-*1* trading arrangement” or “non-Rule *10b5*-*1* trading arrangement,” as each term is defined in Item *408* of Securities and Exchange Commission Regulation S-K."}